{"id":812937,"date":"2025-02-13T12:41:40","date_gmt":"2025-02-13T17:41:40","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\/"},"modified":"2025-02-13T12:41:40","modified_gmt":"2025-02-13T17:41:40","slug":"gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\/","title":{"rendered":"GSK plc Sued for Securities Law Violations \u2013 Investors Should Contact Levi & Korsinsky for More Information \u2013 GSK"},"content":{"rendered":"
\n

NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in GSK plc<\/strong> (“GSK” or the “Company”) (NYSE: GSK) of a class action securities lawsuit.<\/p>\n

\n CLASS DEFINITION: <\/strong>The lawsuit seeks to recover losses on behalf of GSK investors who were adversely affected by alleged securities fraud between February 5, 2020 and August 14, 2022. Follow the link below to get more information and be contacted by a member of our team:<\/p>\n

\n https:\/\/zlk.com\/pslra-1\/gsk-lawsuit-submission-form?prid=128991&wire=3<\/a>\u00a0<\/p>\n

\n GSK<\/strong> investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com<\/a>\u00a0or by telephone at (212) 363-7500.<\/p>\n

\n CASE DETAILS: <\/strong>According to the filed complaint, defendants represented to investors that GSK removed Zantac from the market \u201c[b]ased on information available at the time and correspondence with regulators.\u201d GSK also stated that it was \u201ccontinuing with investigations into the potential source of NDMA.\u201d Defendants also assured investors that \u201cGSK, the FDA, and the EMA [European Medicines Agency] have all independently concluded that there is no evidence of a causal association between ranitidine therapy and the development of cancer in patients,\u201d findings that were \u201cconsistent with other ranitidine data published prior to 2019.\u201d Finally, defendants claimed that they could not \u201cquantify or reliably estimate the liability.\u201d These representations were materially false or misleading. In truth, GSK was fully aware of the source of NDMA and had been for nearly 40 years before withdrawing Zantac from the market.<\/p>\n

\n WHAT’S NEXT? <\/strong>If you suffered a loss in GSK during the relevant time frame, you have until April 7, 2025<\/strong>\u00a0to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.<\/p>\n

\n NO COST TO YOU: <\/strong>If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.<\/strong><\/p>\n

\n WHY LEVI & KORSINSKY: <\/strong>Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services\u2019 Top 50 Report as one of the top securities litigation firms in the United States.<\/p>\n

\n CONTACT:<\/strong>
\n
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
jlevi@levikorsinsky.com<\/a>\u00a0
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com<\/a>\u00a0<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in GSK plc (“GSK” or the “Company”) (NYSE: GSK) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of GSK investors who were adversely affected by alleged securities fraud between February 5, 2020 and August 14, 2022. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/gsk-lawsuit-submission-form?prid=128991&wire=3\u00a0 GSK investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: According to the filed complaint, defendants represented to investors that GSK removed Zantac from the market \u201c[b]ased on information available at the time and correspondence … <\/p>\n

Continue reading “GSK plc Sued for Securities Law Violations \u2013 Investors Should Contact Levi & Korsinsky for More Information \u2013 GSK”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-812937","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nGSK plc Sued for Securities Law Violations \u2013 Investors Should Contact Levi & Korsinsky for More Information \u2013 GSK - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GSK plc Sued for Securities Law Violations \u2013 Investors Should Contact Levi & Korsinsky for More Information \u2013 GSK - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in GSK plc (“GSK” or the “Company”) (NYSE: GSK) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of GSK investors who were adversely affected by alleged securities fraud between February 5, 2020 and August 14, 2022. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/gsk-lawsuit-submission-form?prid=128991&wire=3\u00a0 GSK investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: According to the filed complaint, defendants represented to investors that GSK removed Zantac from the market \u201c[b]ased on information available at the time and correspondence … Continue reading "GSK plc Sued for Securities Law Violations \u2013 Investors Should Contact Levi & Korsinsky for More Information \u2013 GSK"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-13T17:41:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1ODIxNSM2NzUwNTk0IzIwMjA0MjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"GSK plc Sued for Securities Law Violations \u2013 Investors Should Contact Levi & Korsinsky for More Information \u2013 GSK\",\"datePublished\":\"2025-02-13T17:41:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\\\/\"},\"wordCount\":439,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1ODIxNSM2NzUwNTk0IzIwMjA0MjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\\\/\",\"name\":\"GSK plc Sued for Securities Law Violations \u2013 Investors Should Contact Levi & Korsinsky for More Information \u2013 GSK - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1ODIxNSM2NzUwNTk0IzIwMjA0MjY=\",\"datePublished\":\"2025-02-13T17:41:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1ODIxNSM2NzUwNTk0IzIwMjA0MjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1ODIxNSM2NzUwNTk0IzIwMjA0MjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GSK plc Sued for Securities Law Violations \u2013 Investors Should Contact Levi & Korsinsky for More Information \u2013 GSK\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GSK plc Sued for Securities Law Violations \u2013 Investors Should Contact Levi & Korsinsky for More Information \u2013 GSK - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\/","og_locale":"en_US","og_type":"article","og_title":"GSK plc Sued for Securities Law Violations \u2013 Investors Should Contact Levi & Korsinsky for More Information \u2013 GSK - Market Newsdesk","og_description":"NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in GSK plc (“GSK” or the “Company”) (NYSE: GSK) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of GSK investors who were adversely affected by alleged securities fraud between February 5, 2020 and August 14, 2022. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/gsk-lawsuit-submission-form?prid=128991&wire=3\u00a0 GSK investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: According to the filed complaint, defendants represented to investors that GSK removed Zantac from the market \u201c[b]ased on information available at the time and correspondence … Continue reading \"GSK plc Sued for Securities Law Violations \u2013 Investors Should Contact Levi & Korsinsky for More Information \u2013 GSK\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-13T17:41:40+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1ODIxNSM2NzUwNTk0IzIwMjA0MjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"GSK plc Sued for Securities Law Violations \u2013 Investors Should Contact Levi & Korsinsky for More Information \u2013 GSK","datePublished":"2025-02-13T17:41:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\/"},"wordCount":439,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1ODIxNSM2NzUwNTk0IzIwMjA0MjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\/","name":"GSK plc Sued for Securities Law Violations \u2013 Investors Should Contact Levi & Korsinsky for More Information \u2013 GSK - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1ODIxNSM2NzUwNTk0IzIwMjA0MjY=","datePublished":"2025-02-13T17:41:40+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1ODIxNSM2NzUwNTk0IzIwMjA0MjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1ODIxNSM2NzUwNTk0IzIwMjA0MjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-plc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-gsk\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"GSK plc Sued for Securities Law Violations \u2013 Investors Should Contact Levi & Korsinsky for More Information \u2013 GSK"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/812937","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=812937"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/812937\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=812937"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=812937"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=812937"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}